pharma · Duchenne Muscular Dystrophy · Gastroparesis · PCSA
Processa Pharmaceuticals
Processa Pharmaceuticals is a pharma organization headquartered in Hanover, USA. It trades on NYSE under ticker PCSA. Primary therapeutic focus areas include Duchenne Muscular Dystrophy, Gastroparesis, Necrobiosis Lipoid
Hanover, USA HQ
16 Employees
Public company Type
PCSA · NYSE Ticker
Company details
- Status
- Public
- HQ
- Hanover, USA
- Employees
- 16
- Programs
- 8
- Drugs
- 2
- Patents
- 0
PCS6422 and capecitabine
Phase 2 · small molecule · Breast Cancer
PCS6422 and capecitabine for Breast Cancer is a Phase 2 program (small_molecule) at Processa Pharmaceuticals with 1 ClinicalTrials.gov record(s).
Internal code PCS6422-BC-01
Full intelligence profile for this program is being prepared.
At a glance
- Sponsor
- Processa Pharmaceuticals
- Phase
- Phase 2
- Modality
- small_molecule
- Indication
- Breast Cancer
- Status
- active
- Trials
- 1